November 25, 2024

wild grizzly bear

bugsmith

My dear long-time readers certainly remember that I paid special attention to multi-factor stock exchange-traded funds. Today, I want to evaluate another such instrument, the Global X Adaptive U.S. Factor ETF (NYSE:EXP).I initiate a reportintravenous injection

Folder implement intravenous injection content
Initial balance $10,000 $10,000 $10,000
final balance $18,351 $19,237 $19,901
CAGR 11.67% 12.63% 13.33%
standard deviation 19.64% 18.58% 20.20%
best year 27.45% 31.25% 35.58%
worst year -10.63% -18.16% -13.97%
maximum.retracement -31.57% -23.93% -22.11%
Sharpe ratio 0.56 0.63 0.62
Sortino Ratio 0.82 0.95 1.04
market relevance 0.9 1 0.92

Folder implement dynamic neural network intravenous injection content
Initial balance $10,000 $10,000 $10,000 $10,000
final balance $18,538 $19,199 $19,470 $19,492 USD
CAGR 13.38% 14.19% 14.51% 14.54%
standard deviation 19.76% 18.63% 18.49% 20.39%
best year 27.45% 36.26% 28.76% 28.96%
worst year -0.78% -20.27% -18.16% -13.97%
maximum.retracement -31.57% -25.91% -23.93% -22.11%
Sharpe ratio 0.64 0.7 0.72 0.67
Sortino Ratio 0.94 1.09 1.12 1.16
market relevance 0.89 0.99 1 0.92